SCHEMBL28974757

SCHEMBL28974757

CC(C)(C)OC(=O)N1CC(N2CCN(C(=O)OCc3ccccc3)CC2=O)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
HTT P42858 1/20 0.44
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP2C19 P33261 1/20 0.43
USP30 Q70CQ3 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TMEM97 Q5BJF2 1/20 0.42
SIGMAR1 Q99720 1/20 0.42
JAK2 O60674 1/20 0.42
JAK1 P23458 1/20 0.42
PDE4B Q07343 1/20 0.42
STS P08842 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23163823 1.00 PARP1 (0.47) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL30841381 0.93 USP30 (0.51) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL12526593 0.91 SMN1; SMN2 (0.52) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL30368837 0.91 SMN1; SMN2 (0.52) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL14334288 0.85 SMN1; SMN2 (0.50) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL20339027 0.84 PARP1 (0.46) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL21876995 0.84 SMN1; SMN2 (0.52) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL21458909 0.84 SMN1; SMN2 (0.52) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL17736 0.83 MEN1 (0.49) PARP1SMN1; SMN2NPC1RAB9AHTT
SCHEMBL28636149 0.83 SMN1; SMN2 (0.51) PARP1SMN1; SMN2NPC1RAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115703765-B Substituted triazole derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2025-02-28 CN disclosed
EP-4419525-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER Artios Pharma Limited (GB) 2024-08-28 EP disclosed
CN-118556059-A Heterocyclic compounds for the treatment of cancer 阿提奥斯医药有限公司 2024-08-27 CN disclosed
WO-2023067353-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER ARTIOS PHARMA LIMITED (GB) 2023-04-27 WO disclosed
CN-115703765-A Substituted triazole derivative, preparation method, pharmaceutical composition and application thereof 上海赛默罗生物科技有限公司 2023-02-17 CN disclosed